Cargando…

Editorial: Gut microbiota and gastrointestinal disorders

Detalles Bibliográficos
Autores principales:	Yadegar, Abbas, Nabavi-Rad, Ali, Ochoa-Repáraz, Javier, Ohkusa, Toshifumi, Wang, Yan-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669960/ https://www.ncbi.nlm.nih.gov/pubmed/36405609 http://dx.doi.org/10.3389/fmed.2022.1079787

Ejemplares similares

Editorial: The Role of the Gut Microbiota in Health and Inflammatory Diseases
por: Mangalam, Ashutosh K., et al.
Publicado: (2020)

Gut Microbiota and Chronic Constipation: A Review and Update
por: Ohkusa, Toshifumi, et al.
Publicado: (2019)

Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy
por: Ohkusa, Toshifumi, et al.
Publicado: (2023)

Editorial: Helicobacter pylori infection and antibiotic resistance: clinical, translational and experimental studies
por: Yadegar, Abbas, et al.
Publicado: (2023)

A Gut Feeling: The Importance of the Intestinal Microbiota in Psychiatric Disorders
por: Ochoa-Repáraz, Javier, et al.
Publicado: (2020)

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Editorial: A year in review: discussions in obesity
por: Yadegar, Abbas, et al.
Publicado: (2023)

The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
por: Fakharian, Farzaneh, et al.
Publicado: (2022)

Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.
por: Olyaiee, Alireza, et al.
Publicado: (2022)

Hot topics on fecal microbiota transplantation for the treatment of inflammatory bowel disease
por: Zhang, Xiaochen, et al.
Publicado: (2022)

Editorial: Impact of the gut microbiota on cardiovascular medicine
por: Haghikia, Arash, et al.
Publicado: (2022)

Role of gut microbiota-derived signals in the regulation of gastrointestinal motility
por: Zheng, Zhipeng, et al.
Publicado: (2022)

Gut microbiome and the risk factors in central nervous system autoimmunity
por: Ochoa-Repáraz, Javier, et al.
Publicado: (2014)

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

The association between gut microbiota, cholesterol gallstones, and colorectal cancer
por: Rezasoltani, Sama, et al.
Publicado: (2019)

Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?
por: Balan, Yuvaraj, et al.
Publicado: (2021)

Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a systematic review
por: Shirvani-Rad, Salman, et al.
Publicado: (2023)

Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders
por: Mitrea, Laura, et al.
Publicado: (2022)

Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates
por: Alavifard, Helia, et al.
Publicado: (2023)

Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders
por: Liptak, Robert, et al.
Publicado: (2021)

Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
por: Jung, Jang Han, et al.
Publicado: (2022)

Editorial: Manipulation of gut microbiota as a key target to intervene on the onset and progression of digestive system diseases
por: Shi, Ding, et al.
Publicado: (2022)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Editorial: Gut Microbiota in the Occurrence, Development and Treatment of Gut-Brain Disorders
por: Li, Shengjie, et al.
Publicado: (2021)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders
por: Fukui, Hirokazu, et al.
Publicado: (2018)

Editorial: Chronology of gastrointestinal cancers and gastrointestinal microbiota
por: Mi, Yang, et al.
Publicado: (2023)

Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
por: Hoffman, Kristina, et al.
Publicado: (2023)

Corrigendum to “Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation” [Heliyon 9(9) (September 2023) e19607]
por: Noori, Maryam, et al.
Publicado: (2023)

Helicobacter pylori infection contributes to the expression of Alzheimer's disease-associated risk factors and neuroinflammation
por: Noori, Maryam, et al.
Publicado: (2023)

Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders
por: Karakan, Tarkan, et al.
Publicado: (2021)

Editorial: Recent updates in advanced gastrointestinal endoscopy
por: Perisetti, Abhilash, et al.
Publicado: (2023)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation
por: Nabavi-Rad, Ali, et al.
Publicado: (2023)

Special Issue “Gastrointestinal Microbiota and Gut Barrier Impact Human Health and Disease”: Editorial
por: Raoul, Pauline, et al.
Publicado: (2023)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

A Complex Scenario of Nonsteroidal Anti-inflammatory Drugs Induced Prostaglandin E2 Production and Gut Microbiota Alteration in Clostridium difficile-Infected Mice
por: Noori, Maryam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9b9dind6lt4kkfeiu2rl7n1466